Bone metastases are common in patients with advanced cancer. Bisphosphonates (BPs) could prevent or delay the development of skeleton-related events (SREs). The present study aimed to identify the clinical fea...
from Cancer via ola Kala on Inoreader http://ift.tt/1TtbMy0
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου